Programme
Short communications A2
Monday 22 May 2017
13:30-15:00
Stockholmsmässan : K2
Chair: Michael Sorich / Australia
Co-chair: Nebojsa Mihajlica / Sweden
1 |
Optimization of drug delivery to tissues and avoiding drug induced phospholipidosis
|
Irena Loryan |
Sweden, Germany, Netherlands |
2 |
Evaluation of DILI predictive hypotheses in early drug development
|
Rosa Chan |
USA |
3 |
Magnetically bioprinted three dimensional scaffold-free liver model for nanotoxicity studies
|
Iqbal Ramzan |
Australia |
4 |
A comparison of two different self immolative linker strategies in the design of lymph directing, triglyceride mimetic prodrugs of buprenorphine
|
Sifei Han |
Australia |
5 |
Revealing multiple biochemical response patterns of remoxipride by integrating pharmacometabolomics and pharmacokinetic/pharmacodynamic modeling
|
Willem van den Brink |
Netherlands, UK |
6 |
Development of a novel method to estimate chronological changes of long-term progression of chronic diseases
|
Masashi Honma |
Japan |